$AMKR ripped +20% after hours on a $1.5B advanced packaging deal with $NVDA, and it's holding most of that gap, still up mid-teens percent this morning. That deal alone is worth roughly 20% of AMKR's annual revenue, this isn't a headline pump, it's a legit re-rating catalyst. If you're holding or considering covered calls here, expect elevated IV pricing in follow-through, premiums should be juicy on the next roll.
Aggregated and distilled by Two Sentence Traders. Not financial advice.